Top Healthcare Cash-Rich Stocks
Top healthcare companies ranked by cash & equivalents, latest annual filings.
What Cash Reserves Mean for Healthcare Companies
Cash and equivalents captures the liquid balances a firm can deploy on short notice. In healthcare, the figure plays a split role, because a clinical-stage biotech with years of trial spending ahead reads cash very differently from a mature pharmaceutical firm using its balance sheet as an acquisition war chest. For one, reserves are runway; for the other, they are optionality to license or acquire pipeline when internal research falls short.
Why Cash Matters in Healthcare
For pre-revenue biotechs a cash balance that covers several trial readouts gives management the ability to fund science without fresh dilution, which materially affects shareholder returns on a successful compound. For large pharma, cash is ammunition for licensing and bolt-on deals. The meaning depends entirely on burn rate and pipeline stage, so a dollar figure without context of monthly operating outflows or development timelines can be genuinely misleading in this sector.
What to Read Alongside
Pair cash reserves with [Long-term Debt](/financials/most-indebted-stocks/healthcare/) to derive the net cash position, [Free Cash Flow](/financials/top-free-cash-flow-stocks/healthcare/) to separate self-funding firms from those steadily burning through reserves, and [R&D Spending](/financials/top-rd-spending-stocks/healthcare/) to see how balances translate into pipeline investment.
| # | Symbol | Company | Sector | ||
|---|---|---|---|---|---|
| 1 | UNH | UnitedHealth Group Incorporated | Healthcare | $24.36B | $382.76B |
| 2 | JNJ | Johnson & Johnson | Healthcare | $19.71B | $616.50B |
| 3 | CNC | Centene Corporation | Healthcare | $17.89B | $30.05B |
| 4 | MRK | Merck & Co., Inc. | Healthcare | $14.56B | $320.56B |
| 5 | NVS | Novartis AG | Healthcare | $11.44B | $301.15B |
| 6 | BMY | Bristol-Myers Squibb Company | Healthcare | $10.21B | $132.45B |
| 7 | TMO | Thermo Fisher Scientific, Inc. | Healthcare | $9.85B | $214.34B |
| 8 | ELV | Elevance Health, Inc. | Healthcare | $9.49B | $81.63B |
| 9 | AMGN | Amgen Inc. | Healthcare | $9.13B | $209.21B |
| 10 | ABT | Abbott Laboratories | Healthcare | $8.52B | $182.75B |
| 11 | CVS | CVS Health Corporation | Healthcare | $8.45B | $134.25B |
| 12 | CI | The Cigna Group | Healthcare | $7.68B | $76.10B |
| 13 | GILD | Gilead Sciences, Inc. | Healthcare | $7.56B | $162.99B |
| 14 | LLY | Eli Lilly & Co. | Healthcare | $7.27B | $1029.93B |
| 15 | AZN | AstraZeneca PLC | Healthcare | $5.71B | $265.73B |
| 16 | ABBV | AbbVie Inc. | Healthcare | $5.23B | $454.79B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | $5.08B | $122.26B |
| 18 | DHR | Danaher Corporation | Healthcare | $4.62B | $137.90B |
| 19 | ONC | BeOne Medicines AG | Healthcare | $4.55B | $33.42B |
| 20 | GEHC | GE HealthCare Technologies Inc. | Healthcare | $4.49B | $31.59B |
| 21 | COR | Cencora, Inc. | Healthcare | $4.36B | $60.75B |
| 22 | MOH | Molina Healthcare, Inc. | Healthcare | $4.25B | $10.16B |
| 23 | HUM | Humana Inc. | Healthcare | $4.20B | $44.03B |
| 24 | SYK | Stryker Corporation | Healthcare | $4.01B | $133.42B |
| 25 | MCK | McKesson Corporation | Healthcare | $3.98B | $101.33B |
| 26 | TEVA | Teva Pharmaceutical Industries Limited | Healthcare | $3.56B | $41.23B |
| 27 | ARGX | argenx SE | Healthcare | $3.49B | $54.59B |
| 28 | ISRG | Intuitive Surgical, Inc. | Healthcare | $3.37B | $126.46B |
| 29 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | $3.12B | $76.02B |
| 30 | INCY | Incyte Corporation | Healthcare | $3.10B | $24.93B |
| 31 | BIIB | Biogen Inc. | Healthcare | $3.01B | $30.72B |
| 32 | EW | Edwards Lifesciences Corporation | Healthcare | $2.94B | $50.05B |
| 33 | THC | Tenet Healthcare Corporation | Healthcare | $2.88B | $20.35B |
| 34 | CAH | Cardinal Health, Inc. | Healthcare | $2.78B | $53.18B |
| 35 | OSCR | Oscar Health, Inc. | Healthcare | $2.77B | $9.42B |
| 36 | MRNA | Moderna, Inc. | Healthcare | $2.60B | $22.98B |
| 37 | ZTS | ZOETIS INC. | Healthcare | $2.45B | $31.87B |
| 38 | IQV | IQVIA Holdings Inc. | Healthcare | $1.98B | $39.14B |
| 39 | BAX | Baxter International Inc. | Healthcare | $1.97B | $13.82B |
| 40 | BSX | Boston Scientific Corporation | Healthcare | $1.97B | $68.37B |
| 41 | HOLX | Hologic, Inc. | Healthcare | $1.96B | $16.97B |
| 42 | MDT | Medtronic plc | Healthcare | $1.95B | $109.71B |
| 43 | MDLN | Medline Inc. | Healthcare | $1.94B | $33.08B |
| 44 | VEEV | Veeva Systems Inc. | Healthcare | $1.90B | $32.74B |
| 45 | A | Agilent Technologies Inc. | Healthcare | $1.76B | $39.18B |
| 46 | GMAB | Genmab A/S | Healthcare | $1.72B | $17.58B |
| 47 | UTHR | United Therapeutics Corporation | Healthcare | $1.56B | $26.19B |
| 48 | ALNY | Alnylam Pharmaceuticals, Inc. | Healthcare | $1.49B | $27.50B |
| 49 | ROIV | Roivant Sciences Ltd. | Healthcare | $1.42B | $24.94B |
| 50 | ILMN | Illumina, Inc. | Healthcare | $1.42B | $31.03B |
| 51 | JAZZ | Jazz Pharmaceuticals plc | Healthcare | $1.39B | $16.23B |
| 52 | VTRS | Viatris Inc. | Healthcare | $1.32B | $20.68B |
| 53 | WBA | Walgreens Boots Alliance, Inc. | Healthcare | $1.32B | $10.37B |
| 54 | BMRN | BioMarin Pharmaceutical Inc. | Healthcare | $1.31B | $11.71B |
| 55 | BHC | Bausch Health Companies Inc. | Healthcare | $1.31B | $2.25B |
| 56 | NVST | Envista Holdings Corporation | Healthcare | $1.21B | $4.52B |
| 57 | RMD | ResMed Inc. | Healthcare | $1.21B | $30.25B |
| 58 | PFE | Pfizer Inc. | Healthcare | $1.14B | $141.97B |
| 59 | ALGN | Align Technology, Inc. | Healthcare | $1.09B | $12.42B |
| 60 | NTRA | Natera, Inc. | Healthcare | $1.08B | $38.62B |
| 61 | HCA | HCA Healthcare, Inc. | Healthcare | $1.04B | $85.69B |
| 62 | PTCT | PTC Therapeutics, Inc. | Healthcare | $0.98B | $6.26B |
| 63 | EXAS | Exact Sciences Corp | Healthcare | $0.96B | $20.03B |
| 64 | RVTY | Revvity, Inc. | Healthcare | $0.92B | $12.67B |
| 65 | DXCM | DexCom, Inc. | Healthcare | $0.92B | $28.76B |
| 66 | IMVT | Immunovant, Inc. | Healthcare | $0.90B | $8.11B |
| 67 | LEGN | Legend Biotech Corporation | Healthcare | $0.90B | $3.69B |
| 68 | DYN | Dyne Therapeutics, Inc. | Healthcare | $0.89B | $4.80B |
| 69 | SOLV | Solventum Corporation | Healthcare | $0.88B | $15.04B |
| 70 | QGEN | Qiagen N.V. | Healthcare | $0.84B | $8.55B |
| 71 | SRPT | Sarepta Therapeutics, Inc. | Healthcare | $0.80B | $1.64B |
| 72 | GPCR | Structure Therapeutics Inc. | Healthcare | $0.80B | $3.52B |
| 73 | CAI | Caris Life Sciences, Inc. | Healthcare | $0.80B | $4.55B |
| 74 | CRON | Cronos Group Inc. | Healthcare | $0.79B | $1.08B |
| 75 | WST | West Pharmaceutical Services, Inc. | Healthcare | $0.79B | $23.90B |
| 76 | TDOC | Teladoc Health, Inc. | Healthcare | $0.78B | $1.20B |
| 77 | RDNT | RadNet, Inc. | Healthcare | $0.77B | $4.93B |
| 78 | HRMY | Harmony Biosciences Holdings, Inc. | Healthcare | $0.75B | $2.08B |
| 79 | RXRX | Recursion Pharmaceuticals, Inc. | Healthcare | $0.74B | $1.61B |
| 80 | OCUL | Ocular Therapeutix, Inc. | Healthcare | $0.74B | $1.85B |
| 81 | PODD | Insulet Corporation | Healthcare | $0.72B | $11.48B |
| 82 | NBIX | Neurocrine Biosciences, Inc. | Healthcare | $0.71B | $18.65B |
| 83 | ARDT | Ardent Health, Inc. | Healthcare | $0.71B | $1.54B |
| 84 | CPRX | Catalyst Pharmaceuticals Inc | Healthcare | $0.71B | $3.85B |
| 85 | ZLAB | Zai Lab Limited | Healthcare | $0.68B | $2.06B |
| 86 | DVA | DaVita Inc. | Healthcare | $0.68B | $15.33B |
| 87 | IMNM | Immunome, Inc. | Healthcare | $0.65B | $2.61B |
| 88 | ICLR | ICON Public Limited Company | Healthcare | $0.65B | $12.77B |
| 89 | LIVN | LivaNova PLC | Healthcare | $0.64B | $4.45B |
| 90 | RPRX | Royalty Pharma plc | Healthcare | $0.62B | $26.16B |
| 91 | TEM | Tempus AI, Inc. | Healthcare | $0.60B | $7.97B |
| 92 | WVE | Wave Life Sciences Ltd. | Healthcare | $0.60B | $1.13B |
| 93 | ZBH | Zimmer Biomet Holdings, Inc. | Healthcare | $0.59B | $18.37B |
| 94 | WAT | Waters Corporation | Healthcare | $0.59B | $37.34B |
| 95 | ALHC | Alignment Healthcare, Inc. | Healthcare | $0.58B | $3.85B |
| 96 | OGN | Organon & Co. | Healthcare | $0.57B | $3.56B |
| 97 | BBIO | BridgeBio Pharma, Inc. | Healthcare | $0.57B | $16.09B |
| 98 | BDX | Becton, Dickinson and Co. | Healthcare | $0.57B | $45.59B |
| 99 | RGEN | Repligen Corporation | Healthcare | $0.57B | $8.10B |
| 100 | SNN | Smith & Nephew plc | Healthcare | $0.56B | $13.59B |
No companies match this search.
How this ranking is built
Companies are ranked by cash & equivalents as reported in their most recent annual filing with the SEC. Figures shown are in US dollars (or percent, as noted), rounded to two decimals.
- Source: annual 10-K / 20-F filings from companies trading on US exchanges (NYSE, Nasdaq, AMEX).
- Fiscal year: whichever annual period the company has most recently filed. Fiscal years don't always align with the calendar year, so the "as of FY" stamp above reflects the most common year across the table.
- Filtered out: warrants, preferred shares, and duplicate listings that share a parent company's financials.
- Update cadence: refreshed as companies file new annual reports (typically within 60–90 days of fiscal year end).
Not financial advice. This is a research tool, not a recommendation.